DaShenLin Pharmaceutical Hits Day Low of CNY 16.78 Amid Price Pressure

DaShenLin Pharmaceutical Group Co., Ltd. experienced a notable decline today, with the stock dropping by 6.24% on March 23, 2026. The stock reached an intraday low of CNY 16.78, reflecting a challenging trading session. Over the past week, DaShenLin has seen a decrease of 10.3%, while its performance over the past month stands at a decline of 11.65%. In comparison, the China Shanghai Composite index has also faced downward pressure, with a 3.63% loss today and a 6.65% decline over the past week. Despite the recent downturn, DaShenLin has shown resilience over the past year, generating a return of 11.71%, although this is slightly below the Shanghai Composite's 13.33% return. The company maintains a market capitalization of CNY 21,859 million and exhibits a price-to-earnings ratio of 17.00. With a return on equity of 17.03% and a dividend yield of 3.38%, DaShenLin continues to hold a significant position within the pharmaceuticals and biotechnology sector.